« Age Affects Motivation For Quitting Smoking
Importance Of Seeking Immediate Help When Suffering Breathing Problems »

FDA Approves Genzyme’s Renvela For Dialysis Patients

FDA has granted marketing approval for Genzyme’s Renvela (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease on dialysis.

This entry was posted on Monday, October 22nd, 2007 at 11:00 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.